Spear Bio · 1 day ago
Business Development Manager, Immunoassays & Biomarkers
Spear Bio is a rapidly growing biotech start-up dedicated to revolutionizing early disease diagnosis and monitoring. They are seeking a top-performing Business Development Manager to introduce their ultra-sensitive Immunoassays to the Life Sciences and CRO markets, focusing on generating ongoing market adoption and revenue growth.
BiotechnologyHealth CareHealth Diagnostics
Responsibilities
Deliver sales presentations to clients to promote the value proposition of Spear Bio
Demonstrate deep understanding of Neuroscience market dynamics and technology adoption which positions and drives confidence in Spear Bio customers that we are a superior, best-in-class solution
Promote our kit sales by providing various instrument and Assay Service solutions to generate ongoing market adoption and revenue growth
Provide a funnel to be managed by senior Business Development Managers
Be on-point for all customer logistics and follow up: Demos, information sharing, and other key technical details requested to engage our customers
Utilize your existing network of high-level scientific customers within Big Pharma, Biotech, CROs, & Academic market segments, as well as knowledge of IVD markets including LDTs
Support our strategic distribution partnership with Bio-techne, the industry leader in Immunoassays, and leverage their network and contacts to promote the Spear Bio solution. Support Bio-techne in meeting their distribution targets by offering guidance and training in funnel management and understanding key business requirements to meet financial targets of both companies
Achieve a consistent track record exceeding quotas, revenue targets, and increasing market share in your primary territory/region
Provide technical support to many of our Key Opinion Leaders throughout the US/EMEA
Work closely with our internal Marketing team and contribute to driving lead generation programs that can enhance our outreach in all regions
Work closely with our Assay Services leader to support funnel building of this area, as well as provide Voice of Customer (VOC) feedback to our R&D teams on market dynamics gained with our commercial activity
Jointly build a sales plan with personal and professional goals that will provide the best metrics for success in the role
Provide regular updates on activity, forecasting, and funnel movement to assist in the transparency of activity driving strong revenue outcomes
Apply insight on current competitive landscape to develop strategies enabling Spear Bio to win in a competitive market where we have a strong scientific advantage
Approximately 30-40% travel expected directly with customers and/or partners to achieve the sales results expected
Qualification
Required
MS or PhD in Biology, Biochemistry, Bioengineering or related field with 3-5+ years of an established track record in sales or business development, presenting ultrasensitive immunoassays or neurology IVD products to customers
Clear and pro-active communicator with advanced commercial sales acumen, high energy, a strong work ethic, and a bias for action
Ability to ask the right questions of potential customers to then strategically communicate how Spear Bio's differentiated technology and performance will directly benefit them over the competition
Ability to clearly present technology solutions in a way that leads to strong revenue outcomes
Ability to translate observations and customer feedback into strategy
Comfortable providing and receiving feedback designed to improve engagement and results
Ability to collaborate within a best-in-class team environment comprised of Field Application functions, Assay Services, and others
Willingness to travel up to 30-40% for customer engagement and industry events
Benefits
Meaningful stock ownership
Comprehensive benefits
Company
Spear Bio
Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.
Funding
Current Stage
Early StageTotal Funding
$45M2024-07-29Series A· $45M
2023-11-13Seed
Recent News
Precedence Research
2025-11-05
Precedence Research
2025-08-13
Company data provided by crunchbase